1.0329
Cocrystal Pharma Inc stock is traded at $1.0329, with a volume of 15,001.
It is up +0.28% in the last 24 hours and up +6.21% over the past month.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
See More
Previous Close:
$1.03
Open:
$1.0214
24h Volume:
15,001
Relative Volume:
0.15
Market Cap:
$14.34M
Revenue:
-
Net Income/Loss:
$-17.93M
P/E Ratio:
-0.5836
EPS:
-1.77
Net Cash Flow:
$-14.28M
1W Performance:
-1.63%
1M Performance:
+6.21%
6M Performance:
-35.44%
1Y Performance:
-49.79%
Cocrystal Pharma Inc Stock (COCP) Company Profile
Name
Cocrystal Pharma Inc
Sector
Industry
Phone
(786) 459-1831
Address
19805 N. CREEK PARKWAY, BOTHELL, WA
Compare COCP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
COCP
Cocrystal Pharma Inc
|
1.04 | 14.20M | 0 | -17.93M | -14.28M | -1.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.56 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.75 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
867.30 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
360.98 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
335.10 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Cocrystal Pharma Inc Stock (COCP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-08-20 | Initiated | H.C. Wainwright | Buy |
Cocrystal Pharma Inc Stock (COCP) Latest News
Valuation Update: Can Cocrystal Pharma Inc ride the EV waveQuarterly Trade Review & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Trading Action: What are the risks of holding QDWN2025 Analyst Calls & Verified Trade Idea Suggestions - baoquankhu1.vn
Whale Trades: Is Metropolitan Bank Holding Corp. a top pick in the sectorRate Cut & AI Powered Market Entry Strategies - baoquankhu1.vn
Cocrystal Pharma gains IRB approval for norovirus trial - MSN
Inflation Data: Is Cocrystal Pharma Inc benefiting from innovation trendsPortfolio Risk Report & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Cocrystal Pharma Grants Stock Options Under 2025 Incentive Plan - TipRanks
Breakout Watch: Is Cocrystal Pharma Inc. stock risky to hold now - baoquankhu1.vn
MMTC Limited Hits Oversold Level on RSI IndicatorTechnical Pattern Recognition & Enter Your Email to Get Stock Alerts - bollywoodhelpline.com
Bajaj Hindusthan Sugar Limited Breakout Confirmed by Volume MetricsDividend Aristocrats List & Free Gain Edge With Data - bollywoodhelpline.com
Is ESLA stock a smart buy before Fed meetingWeekly Stock Report & Community Consensus Trade Alerts - Улправда
What insider trading reveals about Cocrystal Pharma Inc. stockWeekly Investment Summary & Long-Term Safe Investment Ideas - ulpravda.ru
2026 world cup england qualifiers formations trends2025 Winners & Losers & Free High Return Stock Watch Alerts - Улправда
How buybacks impact Starz Entertainment LLC stock valueTrade Ideas & Free Expert Verified Stock Movement Alerts - Улправда
Easy Fincorp Limited Shows Early Signs of Technical StrengthJuly 2025 PreEarnings & AI Driven Stock Reports - Улправда
Why PTON stock is seen as undervaluedEarnings Performance Report & Smart Swing Trading Alerts - Улправда
Should I hold or sell Cocrystal Pharma Inc. stock in 20252025 Bull vs Bear & Weekly Market Pulse Alerts - ulpravda.ru
Aug Technicals: What insider trading reveals about Cocrystal Pharma Inc. stockPortfolio Performance Summary & Accurate Intraday Trading Signals - Улправда
Will Cocrystal Pharma Inc. stock split attract more investorsWeekly Investment Recap & Accurate Entry/Exit Alerts - Улправда
Is Comstock Holding Companies Inc. (CHO1) stock undervalued at current priceWeekly Stock Summary & Proven Capital Preservation Tips - Улправда
Will Cocrystal Pharma Inc. stock outperform Nasdaq indexQuarterly Trade Summary & High Accuracy Investment Entry Signals - Улправда
Why PFXF stock is trending on social media2025 Support & Resistance & Verified Technical Trade Signals - Улправда
Volume Recap: How strong is CBRE Group Inc. stock revenue growth2025 Dividend Review & AI Based Trade Execution Alerts - ulpravda.ru
Phillip Md Et Al Frost Purchases 50,000 Shares of Cocrystal Pharma (NASDAQ:COCP) Stock - Defense World
Cocrystal Pharma Inc. (COCP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Buyback Watch: How analysts rate Cocrystal Pharma Inc stock todayBull Run & Weekly Watchlist for Hot Stocks - Bộ Nội Vụ
Financial Survey: CytomX Therapeutics (NASDAQ:CTMX) versus Cocrystal Pharma (NASDAQ:COCP) - Defense World
Orient Green Power Company Limited (GREENPOWER) Expands into New MarketSector Leadership Analysis & Exceptional Growth Portfolio - bollywoodhelpline.com
Phillip Frost buys Cocrystal Pharma (COCP) shares worth $63k By Investing.com - Investing.com Nigeria
Live Scanner Shows Breakout on Tube Investments of India LimitedMoving Average Strategies & High Return Capital Gain - bollywoodhelpline.com
Phillip Frost buys Cocrystal Pharma (COCP) shares worth $63k - Investing.com
Aug Decliners: Will Cocrystal Pharma Inc. stock split attract more investors - moha.gov.vn
Chartists See Breakout Potential in Gopal Snacks LimitedGeopolitical Risk Analysis & Small Entry Capital Stocks - bollywoodhelpline.com
Will Cocrystal Pharma Inc. stock benefit from upcoming earnings reportsJuly 2025 Drop Watch & Risk Controlled Swing Trade Alerts - Улправда
Why Cocrystal Pharma Inc. stock is a must watch in 2025Market Performance Summary & Safe Entry Momentum Stock Tips - Улправда
Rally Mode: Will Cocrystal Pharma Inc. stock benefit from upcoming earnings reports2025 Trade Ideas & Safe Capital Growth Stock Tips - Улправда
Why Cocrystal Pharma Inc. (8CC) stock could be top winnerJuly 2025 Sentiment & High Conviction Investment Ideas - moha.gov.vn
Is Cocrystal Pharma Inc. stock a safe haven assetJuly 2025 Price Swings & AI Powered Market Entry Strategies - DonanımHaber
Will Cocrystal Pharma Inc. stock gain from government policiesMarket Volume Summary & Long-Term Capital Growth Ideas - bolumsonucanavari.com
Cocrystal Pharma advances norovirus drug candidate to Phase 1b trial By Investing.com - Investing.com Australia
Can Cocrystal Pharma Inc. stock deliver strong Q4 earnings2025 EndofYear Setup & High Conviction Buy Zone Picks - DonanımHaber
Sentiment Recap: Why Cocrystal Pharma Inc. stock is a must watch in 2025Dip Buying & Short-Term High Return Ideas - Улправда
[8-K] Cocrystal Pharma, Inc. Reports Material Event | COCP SEC FilingForm 8-K - Stock Titan
Cocrystal Pharma, Inc. Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus - marketscreener.com
Cocrystal Pharma (COCP) Set to Begin Norovirus Study with IRB Ap - GuruFocus
Cocrystal Pharma Initiates Phase 1b Study for Norovirus Treatment - TradingView — Track All Markets
Cocrystal Pharma receives IRB approval from Emory University School of Medicine - marketscreener.com
Cocrystal Pharma advances norovirus drug candidate to Phase 1b trial - Investing.com
Cocrystal Pharma Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus - GlobeNewswire
Cocrystal Pharma (NASDAQ:COCP) Shares Down 3.5% – Here’s What Happened - Defense World
Cocrystal Pharma Earnings Notes - Trefis
EPS Watch: Can Cocrystal Pharma Inc. stock deliver strong Q4 earningsQuarterly Investment Review & Reliable Intraday Trade Alerts - moha.gov.vn
Cocrystal Pharma Inc Stock (COCP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cocrystal Pharma Inc Stock (COCP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | Director |
Dec 30 '25 |
Buy |
0.97 |
20,000 |
19,310 |
1,788,551 |
| FROST PHILLIP MD ET AL | Director |
Dec 26 '25 |
Buy |
0.97 |
40,000 |
38,944 |
1,768,551 |
| FROST PHILLIP MD ET AL | Director |
Dec 24 '25 |
Buy |
0.97 |
25,000 |
24,258 |
1,728,551 |
| FROST PHILLIP MD ET AL | Director |
Nov 26 '25 |
Buy |
0.99 |
4,000 |
3,975 |
1,703,551 |
| FROST PHILLIP MD ET AL | Director |
Nov 25 '25 |
Buy |
0.94 |
20,000 |
18,812 |
1,699,551 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):